ICHCC/LinkedIn
May 2, 2026, 10:24
From Gene Mutation to Clot Risk in Factor V Leiden – ICHCC
Iranian Comprehensive Hemophilia Care Center shared a post on LinkedIn:
- is the most common inherited blood clotting disorder in populations of European descent, caused by a mutation in the \(F5\) gene. It makes blood more prone to clotting (thrombophilia) because the mutated Factor V protein resists inactivation by protein C.
- While most carriers never experience a clot, it significantly increases the risk of deep vein thrombosis (DVT) and pulmonary embolism.”
Stay updated with Hemostasis Today.
-
May 2, 2026, 10:15Omid Seidizadeh: Enhancing Diagnostic Strategies for von Willebrand Disease Worldwide
-
May 2, 2026, 10:09Scott McLean: Fewer Bleeds Do Not Always Mean a Better Life in Bleeding Disorders
-
May 2, 2026, 10:01Islam Arid: A Practical Guide to ECMO in Modern Intensive Care
-
May 2, 2026, 09:54The West Virginia Department of Health Announces the Stroke Smart West Virginia Initiative
-
May 2, 2026, 09:38Kim Gannon: Stroke Is Treatable and Outcomes Are Dramatically Better When We Act Fast
-
May 2, 2026, 09:19Rajan Gadhia: Many Strokes Are Preventable with Awareness, Early Recognition, and Timely Action
-
May 2, 2026, 08:34Gary Kurdziel: Closing the Gap Between Onset and Insight in Stroke Care
-
May 2, 2026, 08:25Jackie P Hunter: Black Women, Stroke Risk, and a Very Real Awareness Gap
-
May 2, 2026, 05:24Aaron Kantambo: The Thrombocytic Lineage in Hemostasis and Vascular Repair